• Publications
  • Influence
FOXA1 regulates androgen receptor variant activity in models of castrate-resistant prostate cancer
Retention of androgen receptor (AR) signalling in castrate-resistant prostate cancer (CRPC) highlights the requirement for the development of more effective AR targeting therapies. A key mechanism ofExpand
  • 28
  • 1
  • PDF
Development and exploitation of a novel mutant androgen receptor modelling strategy to identify new targets for advanced prostate cancer therapy
The persistence of androgen receptor (AR) signalling in castrate-resistant prostate cancer (CRPC) highlights the unmet clinical need for the development of more effective AR targeting therapies. AExpand
  • 20
  • 1
  • PDF
Differential regulation of the androgen receptor by protein phosphatase regulatory subunits
The Androgen Receptor (AR) is a key molecule in the development, maintenance and progression of prostate cancer (PC). However, the relationship between the AR and co-regulatory proteins thatExpand
  • 4
  • PDF
FOXA 1 regulates androgen receptor variant activity in models and castrate-resistant prostate cancer
Retention of androgen receptor (AR) signalling in castrate-resistant prostate cancer (CRPC) highlights the requirement for the development of more effective AR targeting therapies. A key mechanism ofExpand
  • 1
  • PDF
Characterising novel phosphatase enzymes important in regulating androgen receptor function in the progression of castrate resistant prostate cancer
..................................................................................................................................... 2 AcknowledgementExpand